CNS Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CNS Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2024.
  • CNS Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 33.4M shares, a 695% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 33.4M +29.2M +695% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.44M -2.7M -65.1% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 10.7M +8.44M +379% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 124K -1.49M -92.3% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 4.21M -35.8M -89.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 4.14M -35.9M -89.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 2.23M -37.8M -94.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1.62M +668K +70.4% Dec 31, 2022 10-K 2024-04-01
Q3 2022 40M +12.6M +45.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 40M +12.7M +46.2% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 40M +14.7M +57.9% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 949K -22.9M -96% Dec 31, 2021 10-K 2023-03-31
Q3 2021 27.5M +10.8M +64.9% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 27.4M +10.9M +66.4% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 25.4M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 23.9M +7.41M +45% Dec 31, 2020 10-K 2022-03-03
Q3 2020 16.7M +3.07M +22.6% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 16.5M Jun 30, 2020 10-Q 2020-08-10
Q4 2019 16.5M 0 0% Dec 31, 2019 10-K 2021-02-12
Q3 2019 13.6M Sep 30, 2019 10-Q 2019-12-20
Q4 2018 16.5M Dec 31, 2018 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.